CORTNEY CASH: Open Payments
NPI 1285967687 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 59 payments from 19 companies in 2025. Trend: 2023 $1,055 · 2024 $1,593 · 2025 $1,420
Food & beverage: $1,303Education: $117
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $370 |
| UCB, Inc. | 7 | $166 |
| Eisai Inc. | 4 | $147 |
| Janssen Biotech, Inc. | 3 | $129 |
| ARGENX US, INC. | 5 | $88 |
| CSL Behring | 3 | $63 |
| Merz Pharmaceuticals, LLC | 2 | $62 |
| SK Life Science, Inc. | 3 | $62 |
| Amgen Inc. | 2 | $60 |
| Alexion Pharmaceuticals, Inc. | 3 | $59 |
Products named: UBRELVY, Leqembi, BOTOX, VYVGART HYTRULO, Rystiggo, Hizentra, UPLIZNA, ULTOMIRIS.
Industry payments across GA — which companies pay providers there.
